Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Atea Pharmaceuticals participates in a conference call with JPMorgan » 11:45
07/20/21
07/20
11:45
07/20/21
11:45
AVIR

Atea Pharmaceuticals

$25.17 /

+0.27 (+1.08%)

Conference call with CEO…

Conference call with CEO Sommadossi, CFO Corcoran, CDO Hammond and CCO Vavricka will be held on July 20 at 12 pm hosted by JPMorgan. Webcast Link

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$25.17 /

+0.27 (+1.08%)

AVIR Atea Pharmaceuticals
$25.17 /

+0.27 (+1.08%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
  • 30
    Oct
AVIR Atea Pharmaceuticals
$25.17 /

+0.27 (+1.08%)

AVIR Atea Pharmaceuticals
$25.17 /

+0.27 (+1.08%)

AVIR Atea Pharmaceuticals
$25.17 /

+0.27 (+1.08%)

Conference/Events
Atea Pharmaceuticals participates in a conference call with JPMorgan » 10:38
07/20/21
07/20
10:38
07/20/21
10:38
AVIR

Atea Pharmaceuticals

$24.82 /

-0.08 (-0.32%)

Conference call with CEO…

Conference call with CEO Sommadossi, CFO Corcoran, CDO Hammond and CCO Vavricka will be held on July 20 at 12 pm hosted by JPMorgan. Webcast Link

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$24.82 /

-0.08 (-0.32%)

AVIR Atea Pharmaceuticals
$24.82 /

-0.08 (-0.32%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
  • 30
    Oct
AVIR Atea Pharmaceuticals
$24.82 /

-0.08 (-0.32%)

AVIR Atea Pharmaceuticals
$24.82 /

-0.08 (-0.32%)

AVIR Atea Pharmaceuticals
$24.82 /

-0.08 (-0.32%)

Over a month ago
On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:59
06/30/21
06/30
12:59
06/30/21
12:59
AMZN

Amazon.com

$3,457.18 /

+10.66 (+0.31%)

, ALT

Altimmune

$9.99 /

-5.9 (-37.13%)

, BBBY

Bed Bath & Beyond

$32.25 /

+2.31 (+7.72%)

, GIS

General Mills

$61.52 /

+1.49 (+2.48%)

, SPCE

Virgin Galactic

$46.36 /

-0.66 (-1.40%)

, CE

Celanese

$150.82 /

+3.77 (+2.56%)

, XOM

Exxon Mobil

$63.02 /

+0.4 (+0.64%)

, FSLY

Fastly

$60.62 /

+0.29 (+0.48%)

, TOSYY

Toshiba

$21.83 /

+0.19 (+0.88%)

, NSANY

Nissan

$10.17 /

-0.07 (-0.68%)

, GOOG

Alphabet

$2,508.61 /

-11.18 (-0.44%)

, GOOGL

Alphabet Class A

$2,436.55 /

-9.91 (-0.41%)

, MSFT

Microsoft

$270.24 /

-1.17 (-0.43%)

, APO

Apollo Global

$62.14 /

-0.24 (-0.38%)

, ASTS

AST SpaceMobile

$14.43 /

+4.225 (+41.40%)

, VTNR

Vertex Energy

$13.11 /

+2.87 (+28.03%)

, HCM

Hutchmed

$40.46 /

+7.2 (+21.65%)

, AVIR

Atea Pharmaceuticals

$21.81 /

-2.6 (-10.65%)

, VXRT

Vaxart

$7.63 /

-0.625 (-7.57%)

, APP

AppLovin

$74.90 /

-8.58 (-10.28%)

, MU

Micron

$84.37 /

+1.47 (+1.77%)

, STX

Seagate

$87.67 /

-0.01 (-0.01%)

, RBLX

Roblox

$90.65 /

-1.81 (-1.96%)

, QUMU

Qumu

$2.87 /

-0.95 (-24.87%)

, DEA

Easterly Government Properties

$21.12 /

+0.2 (+0.96%)

, STZ

Constellation Brands

$235.78 /

+4.22 (+1.82%)

, AVAV

AeroVironment

$97.01 /

-13.05 (-11.86%)

, CRTD

Creatd

$3.72 /

+0.26 (+7.51%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

VTNR Vertex Energy
$13.11 /

+2.87 (+28.03%)

TOSYY Toshiba
$21.83 /

+0.19 (+0.88%)

STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

STX Seagate
$87.67 /

-0.01 (-0.01%)

SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

RBLX Roblox
$90.65 /

-1.81 (-1.96%)

QUMU Qumu
$2.87 /

-0.95 (-24.87%)

NSANY Nissan
$10.17 /

-0.07 (-0.68%)

MU Micron
$84.37 /

+1.47 (+1.77%)

MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

HCM Hutchmed
$40.46 /

+7.2 (+21.65%)

GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

GIS General Mills
$61.52 /

+1.49 (+2.48%)

FSLY Fastly
$60.62 /

+0.29 (+0.48%)

DEA Easterly Government Properties
$21.12 /

+0.2 (+0.96%)

CRTD Creatd
$3.72 /

+0.26 (+7.51%)

CE Celanese
$150.82 /

+3.77 (+2.56%)

BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

AVIR Atea Pharmaceuticals
$21.81 /

-2.6 (-10.65%)

AVAV AeroVironment
$97.01 /

-13.05 (-11.86%)

ASTS AST SpaceMobile
$14.43 /

+4.225 (+41.40%)

APO Apollo Global
$62.14 /

-0.24 (-0.38%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

ALT Altimmune
$9.99 /

-5.9 (-37.13%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

06/24/21 Cowen
Cowen says vote on first antitrust bill encouraging for big tech
06/24/21 Morgan Stanley
Amazon Prime Day revenue up 7% year-over-year, says Morgan Stanley
06/24/21 Piper Sandler
Amazon Prime Day sales rose 13% over last year, says Piper Sandler
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
ALT Altimmune
$9.99 /

-5.9 (-37.13%)

06/30/21 B. Riley
Altimmune price target lowered to $21 from $41 at B. Riley
06/30/21 Guggenheim
Guggenheim names Altimmune a 'Best Idea,' trims price target to $42
06/30/21 H.C. Wainwright
Altimmune price target lowered to $25 from $35 at H.C. Wainwright
06/30/21 JMP Securities
Altimmune price target lowered to $31 from $53 at JMP Securities
BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

06/28/21 Baird
Bed Bath & Beyond Q1 results appear biased to upside, says Baird
06/24/21 BofA
Bed Bath & Beyond upgraded to Buy from Neutral at BofA
06/04/21 BofA
BofA moves to No Rating on Bed Bath & Beyond amid 'meme mania'
05/18/21 Credit Suisse
Bed Bath & Beyond assumed with a Neutral at Credit Suisse
GIS General Mills
$61.52 /

+1.49 (+2.48%)

06/24/21 Piper Sandler
Piper lowers General Mills target on cost inflation headwinds
04/07/21 Piper Sandler
Kellogg snack brands scored well in Piper Sandler teen survey
01/19/21 JPMorgan
General Mills price target lowered to $55 from $62 at JPMorgan
01/12/21 Jefferies
General Mills price target lowered to $59 from $64 at Jefferies
SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 BofA
Virgin Galactic double-downgraded to Underperform from Buy at BofA
06/28/21 Alembic Global
Alembic Global cuts Virgin Galactic to Neutral after 'extraordinary' 39% rally
06/28/21 Alembic Global
Virgin Galactic downgraded to Neutral from Overweight at Alembic Global
CE Celanese
$150.82 /

+3.77 (+2.56%)

06/21/21 Baird
Celanese remains a top pick at Baird
06/09/21 Wolfe Research
Celanese initiated with an Outperform at Wolfe Research
06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 Goldman Sachs
Celanese downgraded to Neutral from Buy at Goldman Sachs
XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

06/30/21 Wells Fargo
Exxon Mobil price target raised to $72 from $67 at Wells Fargo
06/30/21 Citi
Exxon Mobil price target raised to $62 from $56 at Citi
06/16/21 Oppenheimer
MSCI price target raised to $543 from $533 at Oppenheimer
06/09/21 Goldman Sachs
Goldman Sachs keeps Buy on Hess, Exxon Mobil after successful Longtail appraisal
FSLY Fastly
$60.62 /

+0.29 (+0.48%)

06/10/21 RBC Capital
Fastly initiated with a Sector Perform at RBC Capital
06/10/21
Fly Intel: Top five analyst downgrades
06/10/21 Oppenheimer
Oppenheimer downgrades Fastly on increased risk following shutdown
06/10/21 Oppenheimer
Fastly downgraded to Perform from Outperform at Oppenheimer
TOSYY Toshiba
$21.83 /

+0.19 (+0.88%)

03/19/21 SMBC Nikko
Toshiba upgraded to Outperform from Neutral at SMBC Nikko
02/19/21 Citi
Toshiba resumed with a Neutral at Citi
NSANY Nissan
$10.17 /

-0.07 (-0.68%)

02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
12/21/20 SMBC Nikko
Nissan upgraded to Neutral from Underperform at SMBC Nikko
10/28/20 Jefferies
Nissan upgraded to Hold from Underperform at Jefferies
08/03/20 RBC Capital
Renault CEO's H1 results call 'encouraging,' says RBC
GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

06/28/21 Oppenheimer
Trade Desk price target lowered to $85 from $600 at Oppenheimer
06/24/21 Stifel
Google cookie delay pushes out headwind for adtech players, says Stifel
06/24/21 Truist
Google cookie delay pushes out Criteo revenue headwind, says Truist
GOOGL Alphabet Class A
$2,436.55 /

-9.91 (-0.41%)

06/29/21 Argus
Argus expects 'years' for Alphabet antitrust cases to play out
MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

06/28/21 Jefferies
Microsoft price target raised to $310 from $290 at Jefferies
06/23/21 Wedbush
Microsoft price target raised to $325 from $310 at Wedbush
06/16/21 William Blair
Microsoft gaming news opportunity not threat to Unity, says William Blair
06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
APO Apollo Global
$62.14 /

-0.24 (-0.38%)

06/14/21 Citi
Athene Holding price target raised to $66 from $54 at Citi
05/14/21 Truist
Athene Holding price target raised to $68 from $56 at Truist
05/13/21 UBS
Athene Holding downgraded to Neutral from Buy at UBS
05/10/21 Citi
Citi boosts Apollo target to $72, opens 'Positive Catalyst Watch'
ASTS AST SpaceMobile
$14.43 /

+4.225 (+41.40%)

06/30/21 Deutsche Bank
AST SpaceMobile initiated with a Buy at Deutsche Bank
VTNR Vertex Energy
$13.11 /

+2.87 (+28.03%)

06/30/21 Craig-Hallum
Vertex Energy price target raised to $25 from $13 at Craig-Hallum
06/01/21 Stifel
Vertex Energy price target raised to $17 from $2 at Stifel
05/28/21 H.C. Wainwright
Vertex Energy price target raised to $25 from $4 at H.C. Wainwright
05/14/21 Stifel
Vertex Energy upgraded to Buy on cost controls and strong demand at Stifel
HCM Hutchmed
$40.46 /

+7.2 (+21.65%)

10/02/20 Deutsche Bank
Hutchison China MediTech initiated with a Buy at Deutsche Bank
AVIR Atea Pharmaceuticals
$21.81 /

-2.6 (-10.65%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

06/30/21 B. Riley
B. Riley downgraded Vaxart to Neutral on 'riskier development path'
06/29/21 B. Riley
Vaxart downgraded to Neutral from Buy at B. Riley
06/24/21 Jefferies
Vaxart initiated with a Buy at Jefferies
APP AppLovin
$74.90 /

-8.58 (-10.28%)

06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
06/30/21 Morgan Stanley
AppLovin downgraded to Underweight from Overweight at Morgan Stanley
06/04/21 Citi
AppLovin price target raised to $81 from $69 at Citi
MU Micron
$84.37 /

+1.47 (+1.77%)

06/30/21
Fly Intel: Top five analyst upgrades
06/30/21 BMO Capital
Micron upgraded to Outperform from Market Perform at BMO Capital
06/29/21 Citi
Citi reiterates $135 target on Micron, says results to beat esimates
06/28/21 Rosenblatt
Micron reiterated as top pick at Rosenblatt ahead of Q3 earnings
STX Seagate
$87.67 /

-0.01 (-0.01%)

06/30/21 Barclays
Seagate upgraded to Equal Weight from Underweight at Barclays
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Northland
Northland upgrades Seagate to Outperform after pullback dissipates 'Chia froth'
RBLX Roblox
$90.65 /

-1.81 (-1.96%)

06/30/21
Fly Intel: Top five analyst initiations
06/30/21
Roblox initiated with Overweight, $96 price target at Citic
06/30/21
Roblox initiated with an Overweight at Citic Securities
06/16/21 Truist
Truist says May typically a down month for Roblox, June expected higher
QUMU Qumu
$2.87 /

-0.95 (-24.87%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 Craig-Hallum
Qumu downgraded to Hold from Buy at Craig-Hallum
06/11/21 Craig-Hallum
Qumu downgraded to Hold from Buy at Craig-Hallum
02/12/21 Lake Street
Synacor downgraded to Hold from Buy at Lake Street
DEA Easterly Government Properties
$21.12 /

+0.2 (+0.96%)

05/03/21 Citi
Easterly Government Properties resumed with a Buy at Citi
01/12/21 Raymond James
Easterly Government Properties upgraded to Outperform from Market Perform at Raymond James
01/12/21 Raymond James
Easterly upgraded to Outperform from Market Perform at Raymond James
12/23/20 BMO Capital
Easterly Government Properties initiated with an Outperform at BMO Capital
STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

06/28/21 Jefferies
Constellation Brands price target raised to $298 from $295 at Jefferies
06/24/21 Cowen
Constellation Brands post-earnings weakness a buying opportunity, says Cowen
06/18/21 OTR Global
Constellation Brands view downgraded to Mixed from Positive at OTR Global
05/25/21
Fly Intel: Top five analyst initiations
AVAV AeroVironment
$97.01 /

-13.05 (-11.86%)

06/30/21 Canaccord
AeroVironment remains well supported by budget fundamentals, says Canaccord
06/30/21 Baird
AeroVironment core business continues to exhibit growth, says Baird
06/23/21 Canaccord
AeroVironment investors focus on upcoming results and potential, says Canaccord
01/15/21 Stifel
AeroVironment downgraded to Hold from Buy at Stifel
CRTD Creatd
$3.72 /

+0.26 (+7.51%)

XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

STX Seagate
$87.67 /

-0.01 (-0.01%)

SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

RBLX Roblox
$90.65 /

-1.81 (-1.96%)

QUMU Qumu
$2.87 /

-0.95 (-24.87%)

MU Micron
$84.37 /

+1.47 (+1.77%)

MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

HCM Hutchmed
$40.46 /

+7.2 (+21.65%)

GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

GIS General Mills
$61.52 /

+1.49 (+2.48%)

FSLY Fastly
$60.62 /

+0.29 (+0.48%)

DEA Easterly Government Properties
$21.12 /

+0.2 (+0.96%)

CRTD Creatd
$3.72 /

+0.26 (+7.51%)

CE Celanese
$150.82 /

+3.77 (+2.56%)

BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

AVAV AeroVironment
$97.01 /

-13.05 (-11.86%)

APP AppLovin
$74.90 /

-8.58 (-10.28%)

APO Apollo Global
$62.14 /

-0.24 (-0.38%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

ALT Altimmune
$9.99 /

-5.9 (-37.13%)

  • 17
    Jun
  • 15
    Apr
  • 04
    Mar
  • 27
    Jan
  • 30
    Oct
  • 06
    Aug
  • 14
    Jul
XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

TOSYY Toshiba
$21.83 /

+0.19 (+0.88%)

STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

STX Seagate
$87.67 /

-0.01 (-0.01%)

SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

RBLX Roblox
$90.65 /

-1.81 (-1.96%)

NSANY Nissan
$10.17 /

-0.07 (-0.68%)

MU Micron
$84.37 /

+1.47 (+1.77%)

MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

GIS General Mills
$61.52 /

+1.49 (+2.48%)

FSLY Fastly
$60.62 /

+0.29 (+0.48%)

BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

AVIR Atea Pharmaceuticals
$21.81 /

-2.6 (-10.65%)

APO Apollo Global
$62.14 /

-0.24 (-0.38%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

ALT Altimmune
$9.99 /

-5.9 (-37.13%)

XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

VTNR Vertex Energy
$13.11 /

+2.87 (+28.03%)

TOSYY Toshiba
$21.83 /

+0.19 (+0.88%)

STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

STX Seagate
$87.67 /

-0.01 (-0.01%)

SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

RBLX Roblox
$90.65 /

-1.81 (-1.96%)

QUMU Qumu
$2.87 /

-0.95 (-24.87%)

NSANY Nissan
$10.17 /

-0.07 (-0.68%)

MU Micron
$84.37 /

+1.47 (+1.77%)

MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

GIS General Mills
$61.52 /

+1.49 (+2.48%)

FSLY Fastly
$60.62 /

+0.29 (+0.48%)

CRTD Creatd
$3.72 /

+0.26 (+7.51%)

CE Celanese
$150.82 /

+3.77 (+2.56%)

BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

AVIR Atea Pharmaceuticals
$21.81 /

-2.6 (-10.65%)

AVAV AeroVironment
$97.01 /

-13.05 (-11.86%)

ASTS AST SpaceMobile
$14.43 /

+4.225 (+41.40%)

APP AppLovin
$74.90 /

-8.58 (-10.28%)

APO Apollo Global
$62.14 /

-0.24 (-0.38%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

ALT Altimmune
$9.99 /

-5.9 (-37.13%)

XOM Exxon Mobil
$63.02 /

+0.4 (+0.64%)

VXRT Vaxart
$7.63 /

-0.625 (-7.57%)

VTNR Vertex Energy
$13.11 /

+2.87 (+28.03%)

STZ Constellation Brands
$235.78 /

+4.22 (+1.82%)

STX Seagate
$87.67 /

-0.01 (-0.01%)

SPCE Virgin Galactic
$46.36 /

-0.66 (-1.40%)

RBLX Roblox
$90.65 /

-1.81 (-1.96%)

MU Micron
$84.37 /

+1.47 (+1.77%)

MSFT Microsoft
$270.24 /

-1.17 (-0.43%)

HCM Hutchmed
$40.46 /

+7.2 (+21.65%)

GOOGL Alphabet Class A
$2,436.55 /

-9.91 (-0.41%)

GOOG Alphabet
$2,508.61 /

-11.18 (-0.44%)

FSLY Fastly
$60.62 /

+0.29 (+0.48%)

CE Celanese
$150.82 /

+3.77 (+2.56%)

BBBY Bed Bath & Beyond
$32.25 /

+2.31 (+7.72%)

AVIR Atea Pharmaceuticals
$21.81 /

-2.6 (-10.65%)

ASTS AST SpaceMobile
$14.43 /

+4.225 (+41.40%)

APP AppLovin
$74.90 /

-8.58 (-10.28%)

APO Apollo Global
$62.14 /

-0.24 (-0.38%)

AMZN Amazon.com
$3,457.18 /

+10.66 (+0.31%)

Hot Stocks
Atea Pharmaceuticals announces interim results from Phase 2 study of AT-527 » 07:09
06/30/21
06/30
07:09
06/30/21
07:09
AVIR

Atea Pharmaceuticals

$24.41 /

-1.28 (-4.98%)

, RHHBY

Roche

$47.39 /

-0.08 (-0.17%)

Atea Pharmaceuticals…

Atea Pharmaceuticals (AVIR) announced interim results from the global Phase 2 study evaluating AT-527 in hospitalized patients with mild-to-moderate COVID-19. Roche (RHHBY) and Atea are jointly developing AT-527, an oral direct-acting antiviral agent derived from Atea's purine nucleotide prodrug platform. The interim analysis of the Phase 2 study included data from 70 hospitalized, high-risk patients with COVID-19 of which data from 62 patients were evaluable for virology analysis. Interim virology results indicated that AT-527 rapidly reduced viral load levels. At Day 2, patients receiving AT-527 experienced a 0.7 log10 greater mean reduction from baseline viral load as compared to placebo. A sustained difference in viral load reduction was maintained through Day 8. AT-527's SARS-CoV-2 potent antiviral activity was also observed in patients with higher baseline viral loads above the median of 5.26 log10 as compared to placebo. When evaluating a strict RT-qPCR threshold of 500 copies/mL with no detectable ribonucleic acid virus, the AT-527 arm achieved SARS-CoV-2 clearance as early as Day 2, Day 8, Day 10, and Day 12 compared to 0% of patients in the placebo arm at the same timepoints. By Day 14 approximately 47% of patients in the AT-527 arm and 22% in the placebo arm had no detectable RNA virus. Nasopharyngeal swabs were measured in a reverse transcription polymerase chain reaction test for the quantitative detection of nucleic acid from SARS-CoV-2. Consistent with previous studies, AT-527 was generally safe and well tolerated. In this hospitalized study, there were no drug-related serious adverse events. Non-serious adverse events were equally distributed across treatment arms. Most were mild-to-moderate in severity and assessed as not related to the study drug. No safety concerns or newly determined risks were identified. Final data from the full Phase 2 program will be submitted to an upcoming medical congress or a peer-reviewed publication.

ShowHide Related Items >><<
RHHBY Roche
$47.39 /

-0.08 (-0.17%)

AVIR Atea Pharmaceuticals
$24.41 /

-1.28 (-4.98%)

AVIR Atea Pharmaceuticals
$24.41 /

-1.28 (-4.98%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
RHHBY Roche
$47.39 /

-0.08 (-0.17%)

06/14/21 Berenberg
Roche price target raised to CHF 340 from CHF 320 at Berenberg
06/10/21 Morgan Stanley
Roche price target raised to CHF 370 from CHF 345 at Morgan Stanley
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Societe Generale
Roche downgraded to Hold from Buy at Societe Generale
RHHBY Roche
$47.39 /

-0.08 (-0.17%)

  • 30
    Oct
RHHBY Roche
$47.39 /

-0.08 (-0.17%)

AVIR Atea Pharmaceuticals
$24.41 /

-1.28 (-4.98%)

RHHBY Roche
$47.39 /

-0.08 (-0.17%)

AVIR Atea Pharmaceuticals
$24.41 /

-1.28 (-4.98%)

AVIR Atea Pharmaceuticals
$24.41 /

-1.28 (-4.98%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:02
06/17/21
06/17
12:02
06/17/21
12:02
CVAC

CureVac

$54.81 /

-39.89 (-42.12%)

, FSR

Fisker

$18.76 /

+1.03 (+5.81%)

, MGA

Magna

$90.89 /

-2.28 (-2.45%)

, F

Ford

$14.93 /

-0.085 (-0.57%)

, WMT

Walmart

$138.20 /

+1.125 (+0.82%)

, NVAX

Novavax

$182.84 /

+6.42 (+3.64%)

, CODX

Co-Diagnostics

$8.21 /

-0.31 (-3.64%)

, WMG

Warner Music

$34.89 /

-0.14 (-0.40%)

, AVIR

Atea Pharmaceuticals

$23.39 /

-0.06 (-0.26%)

, PFE

Pfizer

$39.17 /

-0.12 (-0.31%)

, DIDI

DiDi

/

+

, NNOX

Nano-X Imaging

$30.33 /

+2.26 (+8.05%)

, AGEN

Agenus

$5.49 /

+0.5 (+10.02%)

, CHPT

ChargePoint

$32.58 /

+1.25 (+3.99%)

, TRCH

Torchlight Energy Resources

$5.06 /

-0.915 (-15.33%)

, AQN

Algonquin Power

$15.26 /

-0.7 (-4.39%)

, LEN

Lennar

$94.90 /

+3.42 (+3.74%)

, HNST

Honest Company

$16.12 /

-1.595 (-9.01%)

, KR

Kroger

$39.11 /

+1.545 (+4.11%)

, JBL

Jabil

$56.95 /

+0.42 (+0.74%)

, CULP

Culp, Inc.

$17.06 /

-0.09 (-0.52%)

, THO

Thor Industries

$102.51 /

-3.82 (-3.59%)

, CWH

Camping World

$35.32 /

-1.67 (-4.51%)

, WGO

Winnebago

$62.30 /

-2.59 (-3.99%)

, NVDA

Nvidia

$751.95 /

+40.42 (+5.68%)

, MU

Micron

$81.23 /

+0.72 (+0.89%)

, PDCO

Patterson Companies

$35.37 /

-0.04 (-0.11%)

, BAND

Bandwidth

$130.48 /

+1.755 (+1.36%)

, KRNL

Kernel Group

$9.75 /

+0.05 (+0.52%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$138.20 /

+1.125 (+0.82%)

WMG Warner Music
$34.89 /

-0.14 (-0.40%)

WGO Winnebago
$62.30 /

-2.59 (-3.99%)

TRCH Torchlight Energy Resources
$5.06 /

-0.915 (-15.33%)

THO Thor Industries
$102.51 /

-3.82 (-3.59%)

PFE Pfizer
$39.17 /

-0.12 (-0.31%)

PDCO Patterson Companies
$35.37 /

-0.04 (-0.11%)

NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

NVAX Novavax
$182.84 /

+6.42 (+3.64%)

NNOX Nano-X Imaging
$30.33 /

+2.26 (+8.05%)

MU Micron
$81.23 /

+0.72 (+0.89%)

MGA Magna
$90.89 /

-2.28 (-2.45%)

LEN Lennar
$94.90 /

+3.42 (+3.74%)

KR Kroger
$39.11 /

+1.545 (+4.11%)

JBL Jabil
$56.95 /

+0.42 (+0.74%)

FSR Fisker
$18.76 /

+1.03 (+5.81%)

F Ford
$14.93 /

-0.085 (-0.57%)

CWH Camping World
$35.32 /

-1.67 (-4.51%)

CVAC CureVac
$54.81 /

-39.89 (-42.12%)

CULP Culp, Inc.
$17.06 /

-0.09 (-0.52%)

CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

AVIR Atea Pharmaceuticals
$23.39 /

-0.06 (-0.26%)

AQN Algonquin Power
$15.26 /

-0.7 (-4.39%)

AGEN Agenus
$5.49 /

+0.5 (+10.02%)

CVAC CureVac
$54.81 /

-39.89 (-42.12%)

06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Guggenheim
CureVac fair value drops to $15-$30 from $90-$110 after failure, says Guggenheim
06/17/21 BofA
CureVac cut to Neutral at BofA after disappointing COVID vaccine data
06/17/21 BofA
CureVac downgraded to Neutral from Buy at BofA
FSR Fisker
$18.76 /

+1.03 (+5.81%)

06/08/21 RBC Capital
Fisker initiated with an Outperform at RBC Capital
06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
05/18/21 Morgan Stanley
Morgan Stanley maintains Overweight rating on Fisker after Q1 report
05/18/21 Barclays
Fisker shares have upside with lockup over, says Barclays
MGA Magna
$90.89 /

-2.28 (-2.45%)

05/31/21 BMO Capital
Magna price target raised to $115 from $108 at BMO Capital
05/10/21 Credit Suisse
Magna price target raised to $120 from $115 at Credit Suisse
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
04/15/21 Barclays
Barclays shuffles ratings in Auto Parts into 'summer recovery'
F Ford
$14.93 /

-0.085 (-0.57%)

06/04/21 JPMorgan
Ford price target raised to $18 from $16 at JPMorgan
05/28/21 Deutsche Bank
Deutsche starts Lordstown with Hold on 'considerable uncertainty'
05/27/21
Fly Intel: Top five analyst upgrades
05/27/21 Jefferies
Ford 'playing to its strengths' with new EV strategy, says Jefferies
WMT Walmart
$138.20 /

+1.125 (+0.82%)

06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
06/07/21 Morgan Stanley
Survey points to Walmart+ membership steady near 10M, says Morgan Stanley
05/24/21 Morgan Stanley
Target price target raised to $250 from $205 at Morgan Stanley
05/19/21 MKM Partners
Walmart price target raised to $152 from $141 at MKM Partners
NVAX Novavax
$182.84 /

+6.42 (+3.64%)

06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

03/29/21 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/29/21 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/26/21 H.C. Wainwright
Co-Diagnostics price target lowered to $16 from $30 at H.C. Wainwright
12/15/20 H.C. Wainwright
Co-Diagnostics price target raised to $30 from $29 at H.C. Wainwright
WMG Warner Music
$34.89 /

-0.14 (-0.40%)

04/22/21 Jefferies
Warner Music initiated with a Hold at Jefferies
03/18/21 Redburn
Redburn sees 40% downside in Warner Music, starts with Sell rating
03/18/21
Fly Intel: Top five analyst initiations
03/18/21 Redburn
Warner Music initiated with a Sell at Redburn
AVIR Atea Pharmaceuticals
$23.39 /

-0.06 (-0.26%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
PFE Pfizer
$39.17 /

-0.12 (-0.31%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
DIDI DiDi
/

+

NNOX Nano-X Imaging
$30.33 /

+2.26 (+8.05%)

04/19/21 Ladenburg
Ladenburg starts Nano-X Imaging at Buy with $52 price target
04/19/21 Ladenburg
Nano-X Imaging initiated with a Buy at Ladenburg
02/01/21 Cantor Fitzgerald
Cantor Fitzgerald reiterates Overweight on Nano-X Imaging, lowers target to $67
09/15/20 Cantor Fitzgerald
Cantor reiterates $70 target on Nano-X after 'unfounded' short report
AGEN Agenus
$5.49 /

+0.5 (+10.02%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

04/16/21
ChargePoint initiated with Buy, $29 target at R.F. Lafferty
03/25/21 Citi
ChargePoint initiated with a Neutral at Citi
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
TRCH Torchlight Energy Resources
$5.06 /

-0.915 (-15.33%)

AQN Algonquin Power
$15.26 /

-0.7 (-4.39%)

05/25/21 Credit Suisse
Algonquin Power price target lowered to C$16.50 from C$17.50 at Credit Suisse
04/14/21 Credit Suisse
Algonquin Power initiated with a Neutral at Credit Suisse
01/27/21 Raymond James
Algonquin Power downgraded to Outperform from Strong Buy at Raymond James
LEN Lennar
$94.90 /

+3.42 (+3.74%)

06/17/21 Wells Fargo
Lennar stock should react positively after quarterly results, says Wells Fargo
04/15/21 Wells Fargo
Lennar initiated with an Equal Weight at Wells Fargo
03/18/21 RBC Capital
Lennar price target raised to $97 from $93 at RBC Capital
03/18/21 BTIG
Lennar price target raised to $117 from $104 at BTIG
HNST Honest Company
$16.12 /

-1.595 (-9.01%)

06/17/21 Loop Capital
Honest Company price target raised to $20 from $18 at Loop Capital
06/17/21 Jefferies
Honest success in skin and personal care encouraging, says Jefferies
06/17/21 JPMorgan
Honest Company should be bought on earnings selloff, says JPMorgan
KR Kroger
$39.11 /

+1.545 (+4.11%)

06/17/21 Wells Fargo
Kroger Q1 update enough to fend off bear case for now, says Wells Fargo
05/04/21
Fly Intel: Top five analyst downgrades
05/04/21 Goldman Sachs
Albertsons downgraded to Neutral from Buy at Goldman Sachs
05/04/21 Goldman Sachs
Kroger downgraded to Sell from Neutral at Goldman Sachs
JBL Jabil
$56.95 /

+0.42 (+0.74%)

05/25/21 Stifel
Plexus warning may be signal that supply constraints will worsen, says Stifel
03/17/21 Argus
Jabil price target raised to $60 from $52 at Argus
03/17/21 Citi
Jabil price target raised to $70 from $60 at Citi
03/16/21 Stifel
Jabil price target raised to $55 from $51 at Stifel
CULP Culp, Inc.
$17.06 /

-0.09 (-0.52%)

09/04/20 Raymond James
Culp, Inc. price target raised to $15 from $12 at Raymond James
THO Thor Industries
$102.51 /

-3.82 (-3.59%)

06/17/21 Northcoast
Northcoast downgrades three RV makers to Neutral following industry checks
06/17/21 Northcoast
Thor Industries downgraded to Neutral from Buy at Northcoast
06/14/21 Exane BNP Paribas
Thor Industries initiated with a Neutral at Exane BNP Paribas
06/09/21 Baird
Thor Industries weakness a buying opportunity, says Baird
CWH Camping World
$35.32 /

-1.67 (-4.51%)

06/17/21 Northcoast
Camping World downgraded to Neutral from Buy at Northcoast
05/05/21 Truist
Camping World price target raised to $56 from $42 at Truist
05/05/21 BMO Capital
Camping World price target raised to $63 from $50 at BMO Capital
WGO Winnebago
$62.30 /

-2.59 (-3.99%)

06/17/21 Northcoast
Winnebago downgraded to Neutral from Buy at Northcoast
05/03/21 Citi
Winnebago price target raised to $93 from $73 at Citi
03/25/21 BMO Capital
Winnebago price target raised to $90 from $88 at BMO Capital
NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

06/17/21 Jefferies
Nvidia price target raised to $854 from $740 at Jefferies
06/08/21 Rosenblatt
Marvell price target raised to $70 from $60 at Rosenblatt
06/03/21 Evercore ISI
Nvidia rallies after Evercore says shares are going higher
MU Micron
$81.23 /

+0.72 (+0.89%)

06/17/21 Lynx
Micron downgraded to Sell from Hold at Lynx
05/28/21 Citi
Lenovo, HP, Dell earnings good news for Intel and AMD, says Citi
05/26/21 Evercore ISI
Micron pullback an 'excellent' buying opportunity, says Evercore ISI
PDCO Patterson Companies
$35.37 /

-0.04 (-0.11%)

06/17/21
Fly Intel: Top five analyst upgrades
06/17/21 Piper Sandler
Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
03/03/21 Piper Sandler
Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
12/30/20 Piper Sandler
Patterson contract loss unexpected but manageable, says Piper Sandler
BAND Bandwidth
$130.48 /

+1.755 (+1.36%)

06/17/21
Fly Intel: Top five analyst initiations
06/17/21 Piper Sandler
Bandwidth initiated with a Neutral at Piper Sandler
04/05/21 Morgan Stanley
Bandwidth upgraded to Equal Weight at Morgan Stanley following underperformance
04/05/21 Morgan Stanley
Bandwidth upgraded to Equal Weight from Underweight at Morgan Stanley
KRNL Kernel Group
$9.75 /

+0.05 (+0.52%)

WMT Walmart
$138.20 /

+1.125 (+0.82%)

WMG Warner Music
$34.89 /

-0.14 (-0.40%)

WGO Winnebago
$62.30 /

-2.59 (-3.99%)

THO Thor Industries
$102.51 /

-3.82 (-3.59%)

PFE Pfizer
$39.17 /

-0.12 (-0.31%)

PDCO Patterson Companies
$35.37 /

-0.04 (-0.11%)

NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

NVAX Novavax
$182.84 /

+6.42 (+3.64%)

NNOX Nano-X Imaging
$30.33 /

+2.26 (+8.05%)

MU Micron
$81.23 /

+0.72 (+0.89%)

MGA Magna
$90.89 /

-2.28 (-2.45%)

LEN Lennar
$94.90 /

+3.42 (+3.74%)

KR Kroger
$39.11 /

+1.545 (+4.11%)

JBL Jabil
$56.95 /

+0.42 (+0.74%)

HNST Honest Company
$16.12 /

-1.595 (-9.01%)

FSR Fisker
$18.76 /

+1.03 (+5.81%)

F Ford
$14.93 /

-0.085 (-0.57%)

CWH Camping World
$35.32 /

-1.67 (-4.51%)

CULP Culp, Inc.
$17.06 /

-0.09 (-0.52%)

CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

BAND Bandwidth
$130.48 /

+1.755 (+1.36%)

AQN Algonquin Power
$15.26 /

-0.7 (-4.39%)

AGEN Agenus
$5.49 /

+0.5 (+10.02%)

  • 05
    May
  • 11
    Feb
  • 08
    Feb
  • 28
    Jan
  • 09
    Dec
  • 03
    Nov
  • 30
    Oct
  • 20
    Aug
  • 21
    Aug
  • 14
    Aug
WMT Walmart
$138.20 /

+1.125 (+0.82%)

WMG Warner Music
$34.89 /

-0.14 (-0.40%)

TRCH Torchlight Energy Resources
$5.06 /

-0.915 (-15.33%)

PFE Pfizer
$39.17 /

-0.12 (-0.31%)

NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

NVAX Novavax
$182.84 /

+6.42 (+3.64%)

MU Micron
$81.23 /

+0.72 (+0.89%)

MGA Magna
$90.89 /

-2.28 (-2.45%)

LEN Lennar
$94.90 /

+3.42 (+3.74%)

KRNL Kernel Group
$9.75 /

+0.05 (+0.52%)

KR Kroger
$39.11 /

+1.545 (+4.11%)

HNST Honest Company
$16.12 /

-1.595 (-9.01%)

FSR Fisker
$18.76 /

+1.03 (+5.81%)

F Ford
$14.93 /

-0.085 (-0.57%)

DIDI DiDi
/

+

CWH Camping World
$35.32 /

-1.67 (-4.51%)

CVAC CureVac
$54.81 /

-39.89 (-42.12%)

CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

AVIR Atea Pharmaceuticals
$23.39 /

-0.06 (-0.26%)

WMT Walmart
$138.20 /

+1.125 (+0.82%)

WMG Warner Music
$34.89 /

-0.14 (-0.40%)

WGO Winnebago
$62.30 /

-2.59 (-3.99%)

THO Thor Industries
$102.51 /

-3.82 (-3.59%)

PFE Pfizer
$39.17 /

-0.12 (-0.31%)

NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

NVAX Novavax
$182.84 /

+6.42 (+3.64%)

NNOX Nano-X Imaging
$30.33 /

+2.26 (+8.05%)

MU Micron
$81.23 /

+0.72 (+0.89%)

MGA Magna
$90.89 /

-2.28 (-2.45%)

LEN Lennar
$94.90 /

+3.42 (+3.74%)

KR Kroger
$39.11 /

+1.545 (+4.11%)

JBL Jabil
$56.95 /

+0.42 (+0.74%)

HNST Honest Company
$16.12 /

-1.595 (-9.01%)

FSR Fisker
$18.76 /

+1.03 (+5.81%)

F Ford
$14.93 /

-0.085 (-0.57%)

DIDI DiDi
/

+

CWH Camping World
$35.32 /

-1.67 (-4.51%)

CVAC CureVac
$54.81 /

-39.89 (-42.12%)

CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

AGEN Agenus
$5.49 /

+0.5 (+10.02%)

WMT Walmart
$138.20 /

+1.125 (+0.82%)

THO Thor Industries
$102.51 /

-3.82 (-3.59%)

PFE Pfizer
$39.17 /

-0.12 (-0.31%)

NVDA Nvidia
$751.95 /

+40.42 (+5.68%)

NVAX Novavax
$182.84 /

+6.42 (+3.64%)

NNOX Nano-X Imaging
$30.33 /

+2.26 (+8.05%)

MU Micron
$81.23 /

+0.72 (+0.89%)

MGA Magna
$90.89 /

-2.28 (-2.45%)

LEN Lennar
$94.90 /

+3.42 (+3.74%)

KR Kroger
$39.11 /

+1.545 (+4.11%)

HNST Honest Company
$16.12 /

-1.595 (-9.01%)

FSR Fisker
$18.76 /

+1.03 (+5.81%)

F Ford
$14.93 /

-0.085 (-0.57%)

CWH Camping World
$35.32 /

-1.67 (-4.51%)

CVAC CureVac
$54.81 /

-39.89 (-42.12%)

CULP Culp, Inc.
$17.06 /

-0.09 (-0.52%)

CODX Co-Diagnostics
$8.21 /

-0.31 (-3.64%)

CHPT ChargePoint
$32.58 /

+1.25 (+3.99%)

AVIR Atea Pharmaceuticals
$23.39 /

-0.06 (-0.26%)

Periodicals
U.S. government to invest $3.2B to develop antiviral pills for Covid, NYT says » 10:43
06/17/21
06/17
10:43
06/17/21
10:43
AVIR

Atea Pharmaceuticals

$23.09 /

-0.36 (-1.54%)

, PFE

Pfizer

$39.20 /

-0.095 (-0.24%)

The U.S. government plans…

The U.S. government plans to invest $3.2B to develop antiviral pills for Covid-19, including AT-527, developed by Atea Pharmaceuticals (AVIR), and PF-07321332, which is made by Pfizer (PFE), The New York Times' Carl Zimmer reports. The new influx of money will speed up the clinical trials of a few promising drug candidates, with some of those pills potentially becoming available by the end of this year, according to the report. Reference Link

ShowHide Related Items >><<
PFE Pfizer
$39.20 /

-0.095 (-0.24%)

AVIR Atea Pharmaceuticals
$23.09 /

-0.36 (-1.54%)

AVIR Atea Pharmaceuticals
$23.09 /

-0.36 (-1.54%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
PFE Pfizer
$39.20 /

-0.095 (-0.24%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
PFE Pfizer
$39.20 /

-0.095 (-0.24%)

  • 30
    Oct
PFE Pfizer
$39.20 /

-0.095 (-0.24%)

PFE Pfizer
$39.20 /

-0.095 (-0.24%)

PFE Pfizer
$39.20 /

-0.095 (-0.24%)

AVIR Atea Pharmaceuticals
$23.09 /

-0.36 (-1.54%)

Hot Stocks
Atea Pharmaceuticals achieves AT-527 milestone under Roche license agreement » 07:04
06/16/21
06/16
07:04
06/16/21
07:04
AVIR

Atea Pharmaceuticals

$23.60 /

-0.17 (-0.72%)

, RHHBY

Roche

$47.77 /

+0.11 (+0.23%)

Atea Pharmaceuticals…

Atea Pharmaceuticals (AVIR) announced that it has achieved a milestone associated with the development of AT-527 and expects to receive a related payment under its license agreement with Roche (RHHBY) of $50M. Under the license agreement, Roche and Atea are jointly developing AT-527 for the treatment of COVID-19. Atea retains rights to commercialize AT-527 in the United States and Roche has the exclusive right to commercialize AT-527 outside of the United States. AT-527 is an orally administered, direct-acting antiviral developmental agent derived from Atea's purine nucleotide prodrug platform and is in Phase 3 development for the treatment of COVID-19. "Working closely with our strategic collaborator Roche, this achievement is reflective of the continual rapid advancement of the AT-527 program," said Jean-Pierre Sommadossi, Ph.D., Founder and CEO of Atea Pharmaceuticals. "The realization of this milestone brings us one step closer to our goal of providing an easily administered oral, direct-acting antiviral in the fight against this global pandemic."

ShowHide Related Items >><<
RHHBY Roche
$47.77 /

+0.11 (+0.23%)

AVIR Atea Pharmaceuticals
$23.60 /

-0.17 (-0.72%)

AVIR Atea Pharmaceuticals
$23.60 /

-0.17 (-0.72%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
RHHBY Roche
$47.77 /

+0.11 (+0.23%)

06/14/21 Berenberg
Roche price target raised to CHF 340 from CHF 320 at Berenberg
06/10/21 Morgan Stanley
Roche price target raised to CHF 370 from CHF 345 at Morgan Stanley
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/02/21 Societe Generale
Roche downgraded to Hold from Buy at Societe Generale
RHHBY Roche
$47.77 /

+0.11 (+0.23%)

  • 30
    Oct
RHHBY Roche
$47.77 /

+0.11 (+0.23%)

RHHBY Roche
$47.77 /

+0.11 (+0.23%)

AVIR Atea Pharmaceuticals
$23.60 /

-0.17 (-0.72%)

Hot Stocks
Atea Pharmaceuticals appoints Jerome Adams to board of directors » 07:17
05/20/21
05/20
07:17
05/20/21
07:17
AVIR

Atea Pharmaceuticals

$22.01 /

-1.48 (-6.30%)

Atea Pharmaceuticals…

Atea Pharmaceuticals announced the appointment of Jerome Adams, M.D., M.P.H., to its Board of Directors. Dr. Adams most recently served as Surgeon General of the United States and brings a wide range of experience spanning clinical practice, clinical research, public health, and government agency leadership.

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$22.01 /

-1.48 (-6.30%)

AVIR Atea Pharmaceuticals
$22.01 /

-1.48 (-6.30%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
  • 30
    Oct
AVIR Atea Pharmaceuticals
$22.01 /

-1.48 (-6.30%)

Over a quarter ago
Hot Stocks
Atea Pharmaceuticals announces first patient dosed in MORNINGSKY trial » 05:43
04/29/21
04/29
05:43
04/29/21
05:43
AVIR

Atea Pharmaceuticals

$26.57 /

-7.025 (-20.91%)

, RHHBY

Roche

$41.50 /

-0.35 (-0.84%)

Atea Pharmaceuticals…

Atea Pharmaceuticals (AVIR) announced that the first patient has been dosed in the Phase 3 MORNINGSKY trial, a multicenter trial evaluating AT-527 in mild or moderate COVID-19 patients in an outpatient setting. The trial, which is anticipated to enroll approximately 1,400 non-hospitalized adults and adolescents with mild to moderate COVID-19, is currently enrolling patients at clinical trial sites outside the United States. MORNINGSKY is expected to have an extensive global footprint and will include a large number of clinical sites worldwide, including Japan. AT-527 is an orally administered, direct-acting antiviral in development and derived from Atea's purine nucleotide prodrug platform. Under a strategic collaboration, Roche (RHHBY) and Atea are jointly developing AT-527 for the treatment of COVID-19.

ShowHide Related Items >><<
RHHBY Roche
$41.50 /

-0.35 (-0.84%)

AVIR Atea Pharmaceuticals
$26.57 /

-7.025 (-20.91%)

AVIR Atea Pharmaceuticals
$26.57 /

-7.025 (-20.91%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
RHHBY Roche
$41.50 /

-0.35 (-0.84%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
03/23/21 Truist
Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
RHHBY Roche
$41.50 /

-0.35 (-0.84%)

  • 30
    Oct
RHHBY Roche
$41.50 /

-0.35 (-0.84%)

RHHBY Roche
$41.50 /

-0.35 (-0.84%)

AVIR Atea Pharmaceuticals
$26.57 /

-7.025 (-20.91%)

AVIR Atea Pharmaceuticals
$26.57 /

-7.025 (-20.91%)

Recommendations
Atea selloff on Merck update unwarranted, says William Blair » 08:59
04/16/21
04/16
08:59
04/16/21
08:59
AVIR

Atea Pharmaceuticals

$46.01 /

-8.315 (-15.31%)

, MRK

Merck

$76.67 /

+0.27 (+0.35%)

William Blair analyst Tim…

William Blair analyst Tim Lugo says the weakness yesterday in shares of Atea Pharmaceuticals (AVIR) after Merck (MRK) provided an update on the development program for molnupiravir, an investigational oral antiviral for the treatment of COVID-19, was unwarranted. Based on a planned interim analysis, Merck decided to discontinue development of molnupiravir in hospitalized patients and to amend the inclusion criteria for the Phase III portion of the outpatient study, Lugo tells investors in a research note. Atea closed down by 15% as investors likely saw read-through from the "seemingly negative updates" from molnupiravir to the company's AT-527 development program, says the analyst. Lugo believes the negative reaction was overdone, noting the inclusion criteria for Atea's ongoing Phase II clinical trials of AT-527 for COVID-19 have always used the more stringent inclusion criteria. Further, while both AT-527 and molnupiravir are nucleoside analogs that target RdRp, they do so using slightly different approaches, says the analyst. Lugo keeps an Outperform rating on Atea Pharmaceuticals.

ShowHide Related Items >><<
MRK Merck
$76.67 /

+0.27 (+0.35%)

AVIR Atea Pharmaceuticals
$46.01 /

-8.315 (-15.31%)

AVIR Atea Pharmaceuticals
$46.01 /

-8.315 (-15.31%)

01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
11/24/20 JPMorgan
Atea Pharmaceuticals initiated with an Overweight at JPMorgan
MRK Merck
$76.67 /

+0.27 (+0.35%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
MRK Merck
$76.67 /

+0.27 (+0.35%)

  • 30
    Oct
MRK Merck
$76.67 /

+0.27 (+0.35%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

AVIR Atea Pharmaceuticals
$46.01 /

-8.315 (-15.31%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

AVIR Atea Pharmaceuticals
$46.01 /

-8.315 (-15.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.